Owner Daiichi Sankyo Co., Ltd

Inventors Yasuda, Hisataka; Morinaga, Tomonori; Tsuda, Eisuke; Kinosaki, Masahiko; Tomoyasu, Akihiro; Kobayashi, Fumie; Washida, Naohiro; Yano, Kazuki; Yamaguchi, Kyoji; Nakagawa, Nobuaki; Takahashi, Ken; Shima, Nobuyuki; Goto, Masaaki

Agent Wrays

Pub. Number AU-B-2008200700

Parent 735355

Filing date 14 February 2008

Wipo publication date 13 March 2008

Acceptance publication date 14 June 2012

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

B01J 20/281 (2006.01) Solid sorbent compositions - Sorbents specially adapted for preparative, analytical or investigative chromatography

C07K 1/22 (2006.01) General processes for the preparation of peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies